Name | (3,4-dinitrophenyl)-morpholin-4-ylmethanone |
---|---|
Synonyms |
Morpholine,4-(3,4-dinitrobenzoyl)
4-(3,4-dinitrobenzoyl)morpholine 4-morpholinocarbonyl-1,2-dinitrobenzene (3,4-dinitrophenyl)-morpholin-4-yl-methanone |
Molecular Formula | C11H11N3O6 |
---|---|
Molecular Weight | 281.22200 |
Exact Mass | 281.06500 |
PSA | 121.18000 |
LogP | 1.95970 |
~94% 65003-28-3 |
Literature: ASTEX THERAPEUTICS LIMITED Patent: WO2007/77435 A1, 2007 ; Location in patent: Page/Page column 235-236; 241 ; WO 2007/077435 A1 |
~96% 65003-28-3 |
Literature: ASTEX THERAPEUTICS LIMITED Patent: WO2008/1101 A2, 2008 ; Location in patent: Page/Page column 289-290; 295 ; |
~% 65003-28-3 |
Literature: ASTEX THERAPEUTICS LIMITED Patent: WO2006/70192 A1, 2006 ; Location in patent: Page/Page column 138-139 ; WO 2006/070192 A1 |
~% 65003-28-3 |
Literature: Zheng, Youguang; Zheng, Ming; Ling, Xin; Liu, Yi; Xue, Yunsheng; An, Lin; Gu, Ning; Jin, Min Bioorganic and Medicinal Chemistry Letters, 2013 , vol. 23, # 12 p. 3523 - 3530 |
Precursor 3 | |
---|---|
DownStream 5 | |